Adherium Limited (ASX:ADR)
0.1000
0.00 (0.00%)
Sep 4, 2026, 9:59 AM AEST
Adherium Market Cap
Adherium has a market cap or net worth of 548.87 million as of September 4, 2026. Its market cap has increased by 5,791.83% in one year.
Market Cap
548.87M
Enterprise Value
549.85M
Revenue
2.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
ChartMarket Cap Chart
Since August 26, 2015, Adherium's market cap has decreased from 732.84M to 548.87M, a decrease of -25.10%. That is a compound annual growth rate of -2.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 548.87M | 3,481.01% |
| Dec 31, 2025 | 15.33M | 44.33% |
| Dec 31, 2024 | 10.62M | -43.13% |
| Dec 29, 2023 | 18.67M | -6.25% |
| Dec 29, 2022 | 19.92M | -17.73% |
| Dec 31, 2021 | 24.21M | 27.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nova Eye Medical | 38.46M |
| CleanSpace Holdings | 37.70M |
| OncoSil Medical | 32.28M |
| Control Bionics | 32.04M |
| ImpediMed | 20.14M |
| Memphasys | 18.52M |
| Atomo Diagnostics | 17.15M |
| Micro-X | 16.55M |